Pure red cell aplasia secondary to treatment with erythropoietin

Artif Organs. 2003 Sep;27(9):755-8. doi: 10.1046/j.1525-1594.2003.00991.x.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Anemia / drug therapy
  • Erythropoietin / adverse effects*
  • Erythropoietin / chemistry
  • Erythropoietin / therapeutic use
  • Humans
  • Recombinant Proteins
  • Red-Cell Aplasia, Pure / chemically induced*

Substances

  • Recombinant Proteins
  • Erythropoietin